Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QCOM vs MRNA✓SelectedUSD · MRNAQCOM vs MRNA performance historyLatest closeAs of-7.45%11/20
Stock and ETF performance explorer

QCOM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-7.8%
MRNA return
-27.3%
Excess return
+19.4%
Maximum drawdown
-44.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-7.5%-2.2%-5.3%-7.3%
7D-13.1%-12.7%-0.4%-12.1%
30D-15.7%-20.7%+4.9%-14.2%
3M-6.2%+46.3%-52.5%-9.4%
6M-25.3%+305.2%-330.5%-40.8%
YTD-11.0%+561.2%-572.2%-37.4%
1Y-4.1%+772.1%-776.2%-36.7%
3Y+23.4%+147.0%-123.6%-0.9%
All-7.8%-27.3%+19.4%-16.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling